"Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System" ed. by Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt
Workshop Summary. Forum on Neuroscience and Nervous System Disorders; Institute of Medicine
NAS Press | 2011 | ISBN: 0309212219 9780309212212 | 75 pages | PDF | 2 MB
Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers.